drugset / Trial / NCT01306682

Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity

NCT01306682

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This randomized, placebo controlled trial will evaluate the safety and immunogenicity of Trivalent Influenza Vaccine (TIV) in HIV-infected pregnant women, dynamics of transplacental anti-influenza antibody transfer to their newborns and kinetics thereof during early infancy.

Timeline

Start
2011-03
Primary completion
2012-06
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications